BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31484695)

  • 1. Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.
    Kraemer MP; Mao G; Hammill C; Yan B; Li Y; Onono F; Smyth SS; Morris AJ
    J Lipid Res; 2019 Nov; 60(11):1818-1828. PubMed ID: 31484695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice.
    Karshovska E; Mohibullah R; Zhu M; Zahedi F; Thomas D; Magkrioti C; Geissler C; Megens RTA; Bianchini M; Nazari-Jahantigh M; Ferreirós N; Aidinis V; Schober A
    Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):1023-1036. PubMed ID: 35708027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
    Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
    Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
    D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
    J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.
    Dusaulcy R; Rancoule C; Grès S; Wanecq E; Colom A; Guigné C; van Meeteren LA; Moolenaar WH; Valet P; Saulnier-Blache JS
    J Lipid Res; 2011 Jun; 52(6):1247-1255. PubMed ID: 21421848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.
    Salgado-Polo F; Fish A; Matsoukas MT; Heidebrecht T; Keune WJ; Perrakis A
    J Biol Chem; 2018 Sep; 293(37):14312-14327. PubMed ID: 30026231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.
    Lin S; Haque A; Raeman R; Guo L; He P; Denning TL; El-Rayes B; Moolenaar WH; Yun CC
    FASEB J; 2019 Mar; 33(3):3623-3635. PubMed ID: 30481488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity.
    Brandon JA; Kraemer M; Vandra J; Halder S; Ubele M; Morris AJ; Smyth SS
    PLoS One; 2019; 14(2):e0208099. PubMed ID: 30730895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis.
    Chattopadhyay A; Mukherjee P; Sulaiman D; Wang H; Girjalva V; Dorreh N; Jacobs JP; Delk S; Moolenaar WH; Navab M; Reddy ST; Fogelman AM
    J Lipid Res; 2023 May; 64(5):100370. PubMed ID: 37059333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin-Lysophosphatidic Acid Axis Acts Downstream of Apoprotein B Lipoproteins in Endothelial Cells.
    Gibbs-Bar L; Tempelhof H; Ben-Hamo R; Ely Y; Brandis A; Hofi R; Almog G; Braun T; Feldmesser E; Efroni S; Yaniv K
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2058-67. PubMed ID: 27562917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
    D'Souza K; Paramel GV; Kienesberger PC
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.
    Plastira I; Bernhart E; Joshi L; Koyani CN; Strohmaier H; Reicher H; Malle E; Sattler W
    J Neuroinflammation; 2020 Apr; 17(1):127. PubMed ID: 32326963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome.
    Kurano M; Suzuki A; Inoue A; Tokuhara Y; Kano K; Matsumoto H; Igarashi K; Ohkawa R; Nakamura K; Dohi T; Miyauchi K; Daida H; Tsukamoto K; Ikeda H; Aoki J; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):463-70. PubMed ID: 25425621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium.
    Zhou Z; Subramanian P; Sevilmis G; Globke B; Soehnlein O; Karshovska E; Megens R; Heyll K; Chun J; Saulnier-Blache JS; Reinholz M; van Zandvoort M; Weber C; Schober A
    Cell Metab; 2011 May; 13(5):592-600. PubMed ID: 21531341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.
    Salous AK; Panchatcharam M; Sunkara M; Mueller P; Dong A; Wang Y; Graf GA; Smyth SS; Morris AJ
    J Lipid Res; 2013 Oct; 54(10):2775-84. PubMed ID: 23948545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.